FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of formula I: 
where R, R1, R2, R3, R4, x and z are determined in items of the invention formula, useful as inhibitors of voltage-gated sodium channels.
EFFECT: invention claims pharmaceutically acceptable compositions, which contain said compounds and methods of applying such compositions for treatment of various diseases.
76 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 4-AMINOQUINAZOLINE ANTAGONISTS OF SELECTIVE SODIUM AND CALCIUM ION CHANNELS | 2004 |
|
RU2378260C2 |
| PYRROLOPYRIMIDINES USED AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2434871C2 |
| TRIAZOLES USED AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2393155C2 |
| PYRAZOLO[1,5-a]PYRIMIDINES, USED AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2417996C2 |
| BENZIMIDAZOLES USED AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2415853C2 |
| METHOD OF PRODUCING DIARYLAMINE | 2004 |
|
RU2351590C2 |
| PYRAZINE DERIVATIVES USED AS ATR KINASE INHIBITORS | 2009 |
|
RU2604066C2 |
| QUINAZOLINE EFFECTIVE AS ION CHANNEL MODULATORS | 2005 |
|
RU2440991C2 |
| ERK2 HETEROCYCLIC INHIBITORS AND THEIR USING | 2002 |
|
RU2300377C2 |
| AZAINDOLES, USEFUL AS INHIBITORS OF JAK AND OTHER PROTEINKINASES | 2005 |
|
RU2403252C2 |
